Nasal Cavity Carcinoma — Trials

Nasal Cavity Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

7 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 6
Recruiting: 3
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06980038	Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer	recruiting	Phase 2	44	National Cancer Institute (NCI)NIH	1	Sep 25, 2026	clinicaltrials
NCT05172245	Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer	recruiting	Phase 1	46	National Cancer Institute (NCI)NIH	2	Sep 22, 2026